FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166423883> ?p ?o ?g. }

• W2166423883 endingPage "PI13" @default.
• W2166423883 startingPage "PI7" @default.
• W2166423883 abstract "Acute decompensation heart failure (ADHF) remains a cause of hospitalization in patients with end-stage congestive HF. The administration of levosimendan in comparison with a standard therapy in CHF patients admitted for ADHF was analysed.Consecutive patients admitted for ADHF (NYHA class III-IV) were treated with levosimendan infusion 0.1 µg/kg/min or with furosemide infusion 100-160 mg per day for 48 hours (control group). All subjects underwent determination of brain natriuretic peptide (BNP), non-invasive cardiac output (CO), and echocardiogram at baseline, at the end of therapy and 1 week after therapy.Seven patients admitted for 20 treatments in 16 months (age 66 years; mean admission/year 5.4) were treated with levosimendan and compared with 7 patients admitted for 15 treatments (age 69.1 years; mean admission/year 6.1). At the end of levosimendan therapy, BNP decreased (from 679.7 ± 512.1 pg/ml to 554.2 ± 407.6 pg/ml p = 0.03), and 6 MWT and LVEF improved (from 217.6 ± 97.7 m to 372.2 ± 90.4 m p = 0.0001; from 22.8 ± 9.1% to 25.4 ± 9.8% p = 0.05). Deceleration time, E/A, E/E', TAPSE, pulmonary pressure and CO did not change significantly after levosimendan therapy and after 1 week. At follow-up, only 6-min WT and NYHA class showed a significant improvement (p = 0.0001, p = 0.001 respectively). The furosemide infusion reduced NYHA class and body weight (from 3.4 ± 0.6 to 2.3 ± 0.5 p = 0.001; from 77.5 ± 8.6 kg to 76 ± 6.6 kg p = 0.04), but impaired renal function (clearances from 56.3 ± 21.9 ml/min to 41.2 ± 10.1 ml/min p = 0.04).Treating end-stage CHF patients with levosimendan improved BNP and LVEF, but this effect disappeared after 1 week. The amelioration of 6 MWT and NYHA class lasted longer after levosimendan infusion." @default.
• W2166423883 created "2016-06-24" @default.
• W2166423883 creator A5003028201 @default.
• W2166423883 creator A5007233636 @default.
• W2166423883 creator A5017352133 @default.
• W2166423883 creator A5021137706 @default.
• W2166423883 creator A5026713109 @default.
• W2166423883 creator A5051010416 @default.
• W2166423883 date "2011-01-01" @default.
• W2166423883 modified "2023-10-17" @default.
• W2166423883 title "Effects of levosimendan/furosemide infusion on Plasma Brain Natriuretic Peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients" @default.
• W2166423883 cites W1978605157 @default.
• W2166423883 cites W1997993335 @default.
• W2166423883 cites W2000876750 @default.
• W2166423883 cites W2002919687 @default.
• W2166423883 cites W2010537966 @default.
• W2166423883 cites W2023606650 @default.
• W2166423883 cites W2027960752 @default.
• W2166423883 cites W2033971063 @default.
• W2166423883 cites W2036330627 @default.
• W2166423883 cites W2039237091 @default.
• W2166423883 cites W2039562601 @default.
• W2166423883 cites W2053409291 @default.
• W2166423883 cites W2058542276 @default.
• W2166423883 cites W2060904229 @default.
• W2166423883 cites W2066118369 @default.
• W2166423883 cites W2083287402 @default.
• W2166423883 cites W2090815068 @default.
• W2166423883 cites W2096073058 @default.
• W2166423883 cites W2101544705 @default.
• W2166423883 cites W2103741220 @default.
• W2166423883 cites W2105095326 @default.
• W2166423883 cites W2106814207 @default.
• W2166423883 cites W2112781257 @default.
• W2166423883 cites W2117483856 @default.
• W2166423883 cites W2123010468 @default.
• W2166423883 cites W2123950172 @default.
• W2166423883 cites W2157204705 @default.
• W2166423883 cites W2171352589 @default.
• W2166423883 cites W2323862874 @default.
• W2166423883 doi "https://doi.org/10.12659/msm.881433" @default.
• W2166423883 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3524718" @default.
• W2166423883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21358614" @default.
• W2166423883 hasPublicationYear "2011" @default.
• W2166423883 type Work @default.
• W2166423883 sameAs 2166423883 @default.
• W2166423883 citedByCount "8" @default.
• W2166423883 countsByYear W21664238832013 @default.
• W2166423883 countsByYear W21664238832015 @default.
• W2166423883 countsByYear W21664238832016 @default.
• W2166423883 countsByYear W21664238832018 @default.
• W2166423883 countsByYear W21664238832020 @default.
• W2166423883 countsByYear W21664238832021 @default.
• W2166423883 countsByYear W21664238832023 @default.
• W2166423883 crossrefType "journal-article" @default.
• W2166423883 hasAuthorship W2166423883A5003028201 @default.
• W2166423883 hasAuthorship W2166423883A5007233636 @default.
• W2166423883 hasAuthorship W2166423883A5017352133 @default.
• W2166423883 hasAuthorship W2166423883A5021137706 @default.
• W2166423883 hasAuthorship W2166423883A5026713109 @default.
• W2166423883 hasAuthorship W2166423883A5051010416 @default.
• W2166423883 hasBestOaLocation W21664238832 @default.
• W2166423883 hasConcept C126322002 @default.
• W2166423883 hasConcept C139940330 @default.
• W2166423883 hasConcept C164705383 @default.
• W2166423883 hasConcept C2775846464 @default.
• W2166423883 hasConcept C2775915353 @default.
• W2166423883 hasConcept C2777335384 @default.
• W2166423883 hasConcept C2777955127 @default.
• W2166423883 hasConcept C2778198053 @default.
• W2166423883 hasConcept C2778721985 @default.
• W2166423883 hasConcept C2779295919 @default.
• W2166423883 hasConcept C71924100 @default.
• W2166423883 hasConcept C78085059 @default.
• W2166423883 hasConcept C84393581 @default.
• W2166423883 hasConceptScore W2166423883C126322002 @default.
• W2166423883 hasConceptScore W2166423883C139940330 @default.
• W2166423883 hasConceptScore W2166423883C164705383 @default.
• W2166423883 hasConceptScore W2166423883C2775846464 @default.
• W2166423883 hasConceptScore W2166423883C2775915353 @default.
• W2166423883 hasConceptScore W2166423883C2777335384 @default.
• W2166423883 hasConceptScore W2166423883C2777955127 @default.
• W2166423883 hasConceptScore W2166423883C2778198053 @default.
• W2166423883 hasConceptScore W2166423883C2778721985 @default.
• W2166423883 hasConceptScore W2166423883C2779295919 @default.
• W2166423883 hasConceptScore W2166423883C71924100 @default.
• W2166423883 hasConceptScore W2166423883C78085059 @default.
• W2166423883 hasConceptScore W2166423883C84393581 @default.
• W2166423883 hasIssue "3" @default.
• W2166423883 hasLocation W21664238831 @default.
• W2166423883 hasLocation W21664238832 @default.
• W2166423883 hasLocation W21664238833 @default.
• W2166423883 hasLocation W21664238834 @default.
• W2166423883 hasOpenAccess W2166423883 @default.
• W2166423883 hasPrimaryLocation W21664238831 @default.
• W2166423883 hasRelatedWork W2166423883 @default.
• W2166423883 hasRelatedWork W2328354663 @default.
• W2166423883 hasRelatedWork W2355594703 @default.

• next